Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftment

Tiago L Laundos; Francisco Vasques-Nóvoa; Rita N Gomes; Vasco Sampaio-Pinto; Pedro Cruz; Hélder Cruz; Jorge M Santos; Rita N Barcia; Perpétua Pinto-do-Ó; Diana S Nascimento

doi:10.3389/fcell.2023.1265005

Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftment

Front Cell Dev Biol. 2023 Aug 18:11:1265005. doi: 10.3389/fcell.2023.1265005. eCollection 2023.

Authors

Tiago L Laundos^{1

2

3}, Francisco Vasques-Nóvoa^{1

2

4

5}, Rita N Gomes^{1

2

3}, Vasco Sampaio-Pinto^{1

2

3}, Pedro Cruz⁶, Hélder Cruz⁶, Jorge M Santos⁶, Rita N Barcia⁶, Perpétua Pinto-do-Ó^{1

2

3}, Diana S Nascimento^{1

2

3}

Affiliations

¹ Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal.
² Instituto Nacional de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal.
³ Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
⁴ Cardiovascular RandD Center, Faculty of Medicine of the University of Porto, Porto, Portugal.
⁵ Department of Internal Medicine, Centro Hospitalar Universitário São João, Porto, Portugal.
⁶ ECBio S.A., Amadora, Portugal.

Abstract

[This corrects the article DOI: 10.3389/fcell.2021.624601.].

Keywords: Wharton’s jelly; cardiac fibrosis; cell therapy; donor variability; mesenchymal stromal (or stem) cells; myocardial infarction; regeneration/repair; umbilical cord matrix derived mesenchymal stromal cells (hUCM-MSCs).

Publication types

Published Erratum